Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.0003 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
260000
Market Cap
0.39M

Momentum Score

…

Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company offers extraction, processing, and co-manufacturing of pharma grade cannabis to produce various derivative cannabis products in the medical and recreational markets. It also manufactures and distributes cannabis products. The company sells product under the Fuego, H&S, and XPLOR brand names. Ayurcann Holdings Corp. is headquartered in Pickering, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.03
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Publicly available information on Ayurcann Holdings Corp (OTCQB: AYURF) is limited; the company is associated with the cannabis/hemp sector. Potential long-term drivers include expanding legal cannabis markets and broader medical and consumer adoption, which could provide small-cap exposure to industry growth for investors willing to accept limited disclosure.

Primary risks are scarce public disclosure and OTC liquidity constraints, combined with regulatory uncertainty and strong competition in the cannabis sector.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
31.28M
Revenue Per Share
0.16
Gross Profit TTM
8.62M
Debt / Equity
-
ROE
-264.42%
Net Debt
-
ROCE
101.71%
Diluted EPS TTM
-0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -3.49M -3.97M -5.31M -1.73M 0.06M
Net income -3.49M -3.97M -5.31M -3.09M -0.28M
Selling general administrative 12.02M 10.53M 8.22M 5.51M 2.46M
Gross profit 10.16M 8.47M 3.68M 3.92M 4.63M
Reconciled depreciation 0.98M 1.24M 0.78M 0.32M 0.28M
Ebit - - - -3.33M 2.16M
Ebitda - - - -1.32M 0.65M
Operating income -2.46M -2.79M -4.99M -1.60M 2.16M
Interest expense 0.66M 0.72M 0.03M 0.09M 0.32M
Tax provision - - 0.00M -0.34M 0.34M
Net interest income -0.66M -0.72M -0.03M -0.09M -0.32M
Income tax expense - - - -0.34M 0.34M
Total revenue 31.11M 25.16M 12.49M 11.08M 7.63M
Total operating expenses 33.57M 27.95M 17.48M 12.68M 5.47M
Cost of revenue 20.95M 16.69M 8.81M 7.17M 3.01M
Total other income expense net -0.36M -0.46M -0.29M -0.04M -1.79M
Net income from continuing ops -3.49M -3.97M -5.31M -1.39M -0.28M
Net income applicable to common shares - - - -3.09M -0.28M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 12.68M 14.85M 12.73M 7.28M 6.68M
Intangible assets 1.20M 1.75M 2.30M - -
Total liab 15.63M 14.32M 10.04M 2.39M 1.93M
Total stockholder equity -2.95M 0.53M 2.69M 4.89M 4.75M
Other current liab - - - - 0.34M
Common stock - - - 8.05M 5.79M
Capital stock 12.95M 12.95M 11.16M 8.05M 5.79M
Retained earnings -17.86M -14.38M -10.41M -5.10M -2.02M
Cash 1.99M 0.39M 0.97M 1.35M 0.73M
Total current liabilities 15.09M 13.60M 9.98M 2.17M 1.57M
Short long term debt 0.04M 0.04M - - -
Other stockholder equity - - - 0.94M 0.13M
Property plant equipment - - - 1.19M 1.25M
Total current assets 10.21M 11.50M 9.27M 6.09M 5.43M
Net tangible assets - - - 4.89M 4.75M
Net receivables 3.96M 5.24M 4.84M 1.54M 2.08M
Long term debt 0.09M 0.13M - 0.04M 0.04M
Inventory 3.72M 5.36M 3.28M 2.95M 2.32M
Accounts payable 3.33M 4.17M 2.07M 0.91M 1.00M
Non current assets total 2.46M 3.36M 3.46M 1.19M 1.25M
Capital lease obligations 0.59M 0.73M 0.18M 0.32M 0.44M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -0.09M -0.44M -0.30M -0.26M 0.36M
Change to liabilities - - - 0.91M 0.95M
Total cashflows from investing activities - - - -0.26M 0.36M
Net borrowings -0.68M -0.05M - -0.18M -0.27M
Total cash from financing activities -0.68M -0.05M 0.19M 0.94M 0.54M
Change to operating activities - - - -0.02M -0.32M
Net income -3.49M -3.97M -5.31M -3.09M -0.28M
Change in cash 1.60M -0.58M -0.38M 0.63M 0.70M
Begin period cash flow 0.39M 0.97M 1.35M 0.73M 0.02M
End period cash flow 1.99M 0.39M 0.97M 1.35M 0.73M
Total cash from operating activities 2.37M -0.10M -0.27M -0.05M -0.20M
Issuance of capital stock - - 0.00M 1.39M 0.77M
Depreciation 0.98M 1.24M 0.78M 0.32M 0.28M
Change to inventory 1.64M -2.09M -0.33M -0.63M -2.04M
Change to account receivables 1.27M -0.39M -3.79M 0.66M -1.71M
Sale purchase of stock - 0.00M -0.02M -0.26M -
Other cashflows from financing activities - - - - 0.04M
Change to netincome - - - 2.15M 2.30M
Capital expenditures 0.09M 0.44M 0.30M 0.26M 0.51M
Change in working capital 4.77M 2.16M 2.34M 0.58M -2.78M
Stock based compensation 0.00M 0.41M 1.53M 2.11M 0.13M
Other non cash items 0.11M 0.07M 0.03M 0.03M 2.44M
Free cash flow 2.28M -0.53M -0.57M -0.31M -0.71M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AYURF
Ayurcann Holdings Corp
-
-%
0.00 - - 0.01 2.70 0.06 -1.05
MKKGY
Merck KGaA ADR
-0.68
2.09%
31.83 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
163.45 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
0.38
1.77%
21.79 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
43.05 - 10.66 0.01 1.16 2.94 23.11

Profile*

Ayurcann Holdings Corp

Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company offers extraction, processing, and co-manufacturing of pharma grade cannabis to produce various derivative cannabis products in the medical and recreational markets. It also manufactures and distributes cannabis products. The company sells product under the Fuego, H&S, and XPLOR brand names. Ayurcann Holdings Corp. is headquartered in Pickering, Canada.

1080 Brock Road, Pickering, ON, Canada, L1W 3X4

905 492 3322

Name Title Year Born
Mr. Igal Sudman Co-Founder, Corp. Sec., CEO & Chairman NA
Mr. Buzaker Roman Co-Founder, Pres, CFO, COO & Director NA
Mr. Raj Virk Head of Quality & Compliance NA
Mr. Igal Sudman Co-Founder, Corporate Secretary, CEO & Chairman NA
Mr. Buzaker Roman Co-Founder, President, COO & Director NA
Mr. Yisroel Zuchter Chief Financial Officer NA
Mr. Roman Buzaker Co-Founder, President, COO & Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…